Skip to main content
OpenTrials
Completed

NCT Number: NCT07063134

Chronic Mouth Breathing and SARS-CoV-2 Positivity in the Pediatric Population

Numerous non-scientific articles on the internet assert the significance of nasal breathing in protecting against COVID-19. Although nasal breathing is anticipated to result in a reduced intake of bioparticles when compared to mouth breathing due to the filtering mechanisms present in the nasal cavity, we have yet to identify any in vivo studies within the literature that definitively ascertain the correlation between mouth breathing and COVID-19 positivity. Consequently, this study aimed to investigate the impact of chronic mouth breathing on testing positive for COVID-19 in children.

Completed

Looking for future studies?

Notify Me

Key information

Age range

10 hour–18 hour

Sex eligibility

All sexes

Study type

Observational

Primary location

Usak University Faculty of Dentistry

Izmir, Turkey (Türkiye)

About this study

Objective Coronavirus disease (COVID-19) is an infectious respiratory illness caused by the SARS-CoV-2 virus. Breathing patterns may influence the transmission of respiratory diseases. Mouth breathing inhaled pollutants and pathogens directly into the lungs. Therefore, this research investigated the impact of chronic mouth breathing on COVID-19 positivity in children.

Materials and Methods A total of 173 patients aged between 10 and 17 years, without any systemic diseases or COVID-19 vaccinations, who were undergoing COVID-19 testing, were included in the study. The age, gender, simplified oral hygiene index, and respiratory models of the included patients were assessed. Patients with a specific malocclusion caused by mouth breathing were diagnosed as "mouth breathers" through clinical assessments. Those who tested positive for COVID-19 were assigned to the experimental group, while those who tested negative were designated as the control group. The differences in mouth breathing rates, simplified oral hygiene index, and sociodemographic data (sex and age) between groups were statistically analysed. Subsequently, the relationship between mouth breathing and the Delta variant was examined.

Results No statistically significant differences were found in sex, breathing pattern, and the simplified oral hygiene index, except for age (p>0.05). The average age of the patients in the experimental group was lower. The Delta variant was more common among chronic mouth breathers (p<0.05).

Conclusion Chronic mouth breathing heightens the risk of transmission, as the pathogenicity of COVID-19 viruses increases.

Clinical relevance Healthcare professionals should possess the knowledge necessary to identify individuals who breathe through their mouths, as this group faces a heightened risk of contracting respiratory diseases.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • tested for COVID-19

Exclusion criteria

  • Not tested for COVID-19

Treatment and study plan

Primary outcomes

  1. Rate of COVID-19 Positivity in Chronic Mouth Breathers Compared to Nasal Breathers

    Time frame: At 2 weeks post-COVID-19 recovery"

    Proportion of COVID-19 positivity among chronic mouth breathers compared to nasal breathers

Sponsors and collaborators

Lead sponsor

Dokuz Eylul University

Other

Registry information

Official study title

Investigation of the Relationship Between Chronic Mouth Breathing and SARS-CoV-2 Positivity in the Pediatric Population

Acronym: BREATH-COV

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jul 14, 2025
Registry last updated
Jul 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.